- Home
- EGHT vs TKNO Comparison
EGHT vs TKNO Comparison
Compare EGHT & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EGHT
- TKNO
- Stock Information
- Founded
- EGHT 1987
- TKNO 1996
- Country
- EGHT United States
- TKNO United States
- Employees
- EGHT N/A
- TKNO N/A
- Industry
- EGHT EDP Services
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- EGHT Technology
- TKNO Health Care
- Exchange
- EGHT Nasdaq
- TKNO Nasdaq
- Market Cap
- EGHT 250.2M
- TKNO 244.7M
- IPO Year
- EGHT 1997
- TKNO 2021
- Fundamental
- Price
- EGHT $1.98
- TKNO $4.84
- Analyst Decision
- EGHT Buy
- TKNO Buy
- Analyst Count
- EGHT 6
- TKNO 2
- Target Price
- EGHT $2.83
- TKNO $5.00
- AVG Volume (30 Days)
- EGHT 880.5K
- TKNO 128.6K
- Earning Date
- EGHT 10-30-2024
- TKNO 11-07-2024
- Dividend Yield
- EGHT N/A
- TKNO N/A
- EPS Growth
- EGHT N/A
- TKNO N/A
- EPS
- EGHT N/A
- TKNO N/A
- Revenue
- EGHT $723,565,000.00
- TKNO $34,940,000.00
- Revenue This Year
- EGHT $0.85
- TKNO $3.22
- Revenue Next Year
- EGHT $2.15
- TKNO $14.88
- P/E Ratio
- EGHT N/A
- TKNO N/A
- Revenue Growth
- EGHT N/A
- TKNO N/A
- 52 Week Low
- EGHT $1.51
- TKNO $1.16
- 52 Week High
- EGHT $3.92
- TKNO $5.46
- Technical
- Relative Strength Index (RSI)
- EGHT 50.41
- TKNO 53.92
- Support Level
- EGHT $1.89
- TKNO $4.47
- Resistance Level
- EGHT $2.20
- TKNO $5.21
- Average True Range (ATR)
- EGHT 0.10
- TKNO 0.39
- MACD
- EGHT 0.02
- TKNO -0.01
- Stochastic Oscillator
- EGHT 37.14
- TKNO 48.60
About EGHT 8x8 Inc
8x8 Inc provides contact-center-as-a-service and unified-communications-as-a-service software applications to approximately 2.5 million users. The company's unified platform enables omnichannel communication to assist employees in communicating across voice, video, text, chat, and contact centers. The Company also generates revenue from sales of hardware and professional services, which are complementary to the delivery of its integrated technology platform.. Geographically, it derives a majority of revenue from the United States.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.